BXRX

Baudax Bio, Inc. Common Stock

Delisted

BXRX was delisted on the 15th of November, 2023.

53 hedge funds and large institutions have $34.8M invested in Baudax Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$5.68M
2 +$3.56M
3 +$3.06M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.62M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.68M
2
$3.56M
3
$3.06M
4
$2.62M
5
$2.02M
6
$1.93M
7
$1.79M
8
$1.35M
9
$1.32M
10
$1.13M
11
$1.08M
12
$850K
13
$769K
14
$761K
15
$707K
16
$685K
17
$557K
18
$556K
19
$522K
20
$459K
21
$417K
22
$346K
23
$296K
24
$198K
25
$188K